The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Application of ferrocene and its derivatives in cancer research
Abstract
The use of ferrocene-based compounds for medicinal applications is an active research area. Many reports have demonstrated that some ferrocenyl derivatives are highly active against several diseases, including cancer. This review focuses on the most relevant examples of ferrocene-based molecules that show anticancer activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daniel, M.-C., & Astruc, D. (2004) · Chemical Reviews · doi:10.1021/cr030698+ · Cited by 12,446
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
Bioorganometallic Chemistry of Ferrocene
van Staveren, D. R., & Metzler-Nolte, N. (2004) · Chemical Reviews · doi:10.1021/cr0101510 · Cited by 1,319
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Non-Platinum Chemotherapeutic Metallopharmaceuticals
Clarke, M. J., Zhu, F., & Frasca, D. R. (1999) · Chemical Reviews · doi:10.1021/cr9804238 · Cited by 908
Lebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture
Fox, M. E., Szoka, F. C., & Fréchet, J. M. J. (2009) · Accounts of Chemical Research · doi:10.1021/ar900035f · Cited by 748
Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Ang, W. H., & Dyson, P. J. (2006) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200600723 · Cited by 713
Dendrimers as Carriers for Delivery of Chemotherapeutic Agents
Medina, S. H., & El-Sayed, M. E. H. (2009) · Chemical Reviews · doi:10.1021/cr900174j · Cited by 669
Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614
Ruthenium Complexes as Anticancer Agents
Kostova, I. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360941 · Cited by 566
Therapeutic and diagnostic applications of dendrimers for cancer treatment☆
WOLINSKY, J., & GRINSTAFF, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.012 · Cited by 540
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
On the medicinal chemistry of ferrocene
Fouda, M. F. R., Abd‐Elzaher, M. M., Abdelsamaia, R. A., & Labib, A. A. (2007) · Applied Organometallic Chemistry · doi:10.1002/aoc.1202 · Cited by 460
Top, S., Vessières, A., Leclercq, G., Quivy, J. I., Tang, J., Vaissermann, J., Huché, M., & Jaouen, G. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200305024 · Cited by 454
Cyclodextrins as Supramolecular Hosts for Organometallic Complexes
Hapiot, F., Tilloy, S., & Monflier, E. (2006) · Chemical Reviews · doi:10.1021/cr050576c · Cited by 416
van Dongen, S. F. M., de Hoog, H.-P. M., Peters, R. J. R. W., Nallani, M., Nolte, R. J. M., & van Hest, J. C. M. (2009) · Chemical Reviews · doi:10.1021/cr900072y · Cited by 386
Ornelas, C., Ruiz, J., Cloutet, É., Alvès, S., & Astruc, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602858 · Cited by 376
Self-citationMetallocenyl Dendrimers and Their Applications in Molecular Electronics, Sensing, and Catalysis
Astruc, D., Ornelas, C., & Ruiz, J. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000074 · Cited by 312
Self-citationOn the mechanism of the antitumor activity of ferrocenium derivatives
Osella, D., Ferrali, M., Zanello, P., Laschi, F., Fontani, M., Nervi, C., & Cavigiolio, G. (2000) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)00147-x · Cited by 266
Ferricenium complexes: A new type of water-soluble antitumor agent
K�pf-Maier, P., K�pf, H., & Neuse, E. W. (1984) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00390468 · Cited by 248
Ornelas, C., Aranzaes, J. R., Salmon, L., & Astruc, D. (2008) · Chemistry – A European Journal · doi:10.1002/chem.200701410 · Cited by 204
Self-citationHelms, B. A., & Meijer, E. W. (2006) · Science · doi:10.1126/science.1130639 · Cited by 202
Dendrimers and gold nanoparticles as exo-receptors sensing biologically important anions
Astruc, D., Daniel, M.-C., & Ruiz, J. (2004) · Chemical Communications · doi:10.1039/b410399h · Cited by 198
Giant Dendritic Molecular Electrochrome Batteries with Ferrocenyl and Pentamethylferrocenyl Termini
Ornelas, C., Ruiz, J., Belin, C., & Astruc, D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8062343 · Cited by 188
Self-citationThe mechanisms of DNA topoisomerases
ROCA, J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88993-8 · Cited by 180
Vessières, A., Top, S., Beck, W., Hillard, E., & Jaouen, G. (2006) · Dalton Trans. · doi:10.1039/b509984f · Cited by 180
Macromolecular Ferrocene Compounds as Cancer Drug Models
Neuse, E. W. (2005) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-004-2371-9 · Cited by 177
Ornelas, C., Broichhagen, J., & Weck, M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910581d · Cited by 167
Self-citationAuzias, M. G., Therrien, B., Süß‐Fink, G., Štěpnička, P., Ang, W. H., & Dyson, P. J. (2007) · Inorganic Chemistry · doi:10.1021/ic7018742 · Cited by 144
A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents
Hillard, E. A., Vessières, A., Bideau, F. L., Plażuk, D., Spera, D., Huché, M., & Jaouen, G. (2006) · ChemMedChem · doi:10.1002/cmdc.200500035 · Cited by 138
Ferrocene Functionalized Endocrine Modulators as Anticancer Agents
Hillard, E. A., Vessières, A., & Jaouen, G. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_4 · Cited by 132
Allard-Vannier, É., Passirani, C., Garcion, E., Pigeon, P., Vessières, A., Jaouen, G., & Benoît, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.027 · Cited by 132
Synthesis and antifungal activity of a ferrocene–fluconazole analogue
Biot, C., François, N., Maciejewski, L. A., Brocard, J. S., & Poulain, D. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00120-7 · Cited by 131
Current Dendrimer Applications in Cancer Diagnosis and Therapy
Majoros, I., Williams, C., & Baker, J. R. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785849049 · Cited by 122
Catalytically efficient palladium nanoparticles stabilized by “click” ferrocenyl dendrimers
Ornelas, C., Salmon, L., Ruiz, J., & Astruc, D. (2007) · Chemical Communications · doi:10.1039/b710925c · Cited by 111
Self-citationPayen, O., Top, S., Vessières, A., Brûlé, E., Plamont, M., McGlinchey, M. J., Müller‐Bunz, H., & Jaouen, G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701264d · Cited by 103
The role of tamoxifen in the treatment and prevention of breast cancer
Jordan, V. C. (1992) · Current Problems in Cancer · doi:10.1016/0147-0272(92)90002-6 · Cited by 100
Astruc, D., Ornelas, C., & Ruiz, J. (2007) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-007-9191-7 · Cited by 99
Self-citationBuriez, O., Heldt, J., Labbé, É., Vessières, A., Jaouen, G., & Amatore, C. A. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800507 · Cited by 82
Polyferrocenes as mediators in amperometric biosensors for glucose
Hendry, S. P., Cardosi, M. F., Turner, A. P. F., & Neuse, E. W. (1993) · Analytica Chimica Acta · doi:10.1016/0003-2670(93)85002-2 · Cited by 79
Top, S., Vessières, A., Pigeon, P., Rager, M., Huché, M., Salomon, E., Cabestaing, C., Vaissermann, J., & Jaouen, G. (2004) · ChemBioChem · doi:10.1002/cbic.200400067 · Cited by 78
Synthesis and Structure Activity Relationship of Organometallic Steroidal Androgen Derivatives
Top, S., Thibaudeau, C., Vessières, A., Brûlé, E., Bideau, F. L., Joerger, J., Plamont, M., Samreth, S., Edgar, A., Marrot, J., et al. (2009) · Organometallics · doi:10.1021/om800698y · Cited by 76
Dendritic Molecular Electrochromic Batteries Based on Redox‐Robust Metallocenes
Astruc, D., Ornelas, C., & Ruiz, J. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200901294 · Cited by 75
Self-citationArmada, M. P. G., Losada, J., Zamora, M., Alonso, B., Cuadrado, I., & Casado, C. M. (2006) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2005.11.005 · Cited by 72
Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment
Anh, N. T. V., Marsaud, V., Bouclier, C., Top, S., Vessières, A., Pigeon, P., Gref, R., Legrand, P., Jaouen, G., & Renoir, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.033 · Cited by 71
Scarcia, V., Furlani, A., Longato, B., Corain, B., & Pilloni, G. (1988) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)83359-9 · Cited by 62
Auzias, M. G., Gueniat, J., Therrien, B., Süß‐Fink, G., Renfrew, A. K., & Dyson, P. J. (2008) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2008.08.012 · Cited by 54
Long, B., Liang, S., Xin, D., Yang, Y., & Xiang, J. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.01.029 · Cited by 54
Kondapi, A. K., Satyanarayana, N., & Saikrishna, A. D. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.04.003 · Cited by 54
Barbosa, C. M. V., Oliveira, C. R., Nascimento, F. D., Smith, M. C. M., Fausto, D. M., Soufen, M. A., Sena, E., Araújo, R. C., Tersariol, I. L. S., Bincoletto, C., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.004 · Cited by 51
Mooney, Á., Corry, A. J., Ruairc, C. N., Mahgoub, T., O'Sullivan, D., O’Donovan, N., Crown, J. P., Varughese, S., Draper, S. M., Rai, D. K., et al. (2010) · Dalton Transactions · doi:10.1039/c0dt00377h · Cited by 45
Novel Mutual Prodrug of Retinoic and Butyric Acids with Enhanced Anticancer Activity
Nudelman, A., & Rephaeli, A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990540a · Cited by 40
Design, synthesis, and antitumor activity of bicyclic and isomeric analogues of illudin M
Kinder, F. R. J., Wang, R.-M., Bauta, W. E., et al. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00167-9 · Cited by 37
Wei, H., Quan, C., Chang, C., Zhang, X., & Zhuo, R. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp100901p · Cited by 34
Ornelas, C., Boisselier, É., Martinez, V., Pianet, I., Ruiz, J., & Astruc, D. (2007) · Chemical Communications · doi:10.1039/b710391c · Cited by 33
Self-citationZekri, O., Hillard, E. A., Top, S., Vessières, A., Pigeon, P., Plamont, M., Huché, M., Boutamine, S., McGlinchey, M. J., Müller-Bunz, H., et al. (2009) · Dalton Transactions · doi:10.1039/b819812h · Cited by 32
9-cis-Retinoids: Biosynthesis of 9-cis-Retinoic Acid
Paik, J., Vogel, S., Piantedosi, R., Sykes, A., Blaner, W. S., & Swisshelm, K. L. (2000) · Biochemistry · doi:10.1021/bi992152g · Cited by 28
Shiina, I., Sano, Y., Nakata, K., Kikuchi, T., Sasaki, A., Ikekita, M., Nagahara, Y., Hasome, Y., Yamori, T., & Yamazaki, K. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.11.005 · Cited by 27
Swarts, J. C., Neuse, E. W., & Lamprecht, G. J. (1994) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/bf01036539 · Cited by 26
Cited by
Why is Ferrocene so Exceptional?
Astruc, D. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201600983 · Cited by 653
The medicinal chemistry of ferrocene and its derivatives
Patra, M., & Gasser, G. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0066 · Cited by 609
Co–Ferrocene MOF/Glucose Oxidase as Cascade Nanozyme for Effective Tumor Therapy
Fang, C., Deng, Z., Cao, G., Chu, Q., Wu, Y., Li, X., Peng, X., & Han, G. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910085 · Cited by 423
Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium
Konkankit, C. C., Marker, S. C., Knopf, K. M., & Wilson, J. J. (2018) · Dalton Transactions · doi:10.1039/c8dt01858h · Cited by 284
Metadata
- Authors
- Ornelas, C.
- Venue
- New Journal of Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2011
- Volume
- 35
- Issue
- 10
- Pages
- 1973
- ISSN
- 0398-9836 (ISSN-L)
- 1144-0546
- 1369-9261
- OpenAlex
- W2151860543
- Cited by
- 473
- References
- 65
- FWCI
- 14.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.